null Option on Opus Genetics
| IRD Stock | 2.12 0.11 5.47% |
Opus Genetics' latest option contracts expiring on February 20th 2026 are carrying combined implied volatility of 1.31 with a put-to-call open interest ratio of 0.0 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on February 20th 2026.
Open Interest Against February 20th 2026 Option Contracts
2026-02-20
The chart above shows Opus Genetics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Opus Genetics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Opus Genetics' option, there is no secondary market available for investors to trade.
Opus Genetics Maximum Pain Price Across 2026-02-20 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Opus Genetics close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Opus Genetics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Opus Genetics
Analyzing Opus Genetics' in-the-money options over time can help investors to take a profitable long position in Opus Genetics regardless of its overall volatility. This is especially true when Opus Genetics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Opus Genetics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Opus Genetics' stock while costing only a fraction of its price.
Opus Genetics' stock options are financial instruments that give investors the right to buy or sell shares of Opus Genetics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Opus stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Opus Genetics' stock price goes up or down, the stock options follow.
As of January 3, 2026, Total Stockholder Equity is expected to decline to about 7.3 M. In addition to that, Common Stock Shares Outstanding is expected to decline to about 17.5 MOpus Current Options Market Mood
Opus Genetics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Opus Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Opus Genetics' options investors are not very successful. Opus Genetics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Opus contract
Base on the Rule 16, the options market is currently suggesting that Opus Genetics will have an average daily up or down price movement of about 0.0819% per day over the life of the 2026-02-20 option contract. With Opus Genetics trading at USD 2.12, that is roughly USD 0.001736. If you think that the market is fully incorporating Opus Genetics' daily price movement you should consider buying Opus Genetics options at the current volatility level of 1.31%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Opus Genetics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Opus calls. Remember, the seller must deliver Opus Genetics stock to the call owner when a call is exercised.
Opus Genetics Option Chain
When Opus Genetics' strike price is surpassing the current stock price, the option contract against Opus Genetics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Opus Genetics' option chain is a display of a range of information that helps investors for ways to trade options on Opus. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Opus. It also shows strike prices and maturity days for a Opus Genetics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | IRD260220C00007500 | 1 | 7.5 | 0.0 - 4.6 | 0.05 | Out |
Call | IRD260220C00005000 | 928 | 5.0 | 0.05 - 0.1 | 0.1 | Out |
Call | IRD260220C00002500 | 1699 | 2.5 | 0.35 - 0.5 | 0.3 | Out |
Put | IRD260220P00007500 | 0 | 7.5 | 3.0 - 7.5 | 3.0 | In |
Put | IRD260220P00005000 | 0 | 5.0 | 0.65 - 5.5 | 0.65 | In |
Put | IRD260220P00002500 | 11 | 2.5 | 0.45 - 1.25 | 0.9 | In |
Opus Genetics Market Cap Over Time
Market Cap |
| Timeline |
Opus Total Stockholder Equity
Total Stockholder Equity |
|
Opus Genetics Corporate Management
| Joseph MBA | Chief Officer | Profile | |
| Jenny Kobin | Investor Officer | Profile | |
| Robert Gagnon | Chief Officer | Profile | |
| Bernhard MBA | Senior Secretary | Profile | |
| Ashwath Jayagopal | Chief Officer | Profile | |
| Bindu Manne | Head Commercialization | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Opus Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.86) | Revenue Per Share | Quarterly Revenue Growth (0.20) | Return On Assets | Return On Equity |
The market value of Opus Genetics is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics' value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics' market value can be influenced by many factors that don't directly affect Opus Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.